<DOC>
	<DOCNO>NCT00790322</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety SBG v placebo oral mucositis head neck cancer patient undergo radiation therapy .</brief_summary>
	<brief_title>Efficacy Safety Study SBG v Placebo Head Neck Cancer Patients Undergoing Radiation Therapy</brief_title>
	<detailed_description>The objective study evaluate efficacy safety soluble beta-1,3/1,6-glucan ( SBG ) oral mucositis compare placebo head neck cancer patient undergo radiation therapy without chemotherapy .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Stomatitis</mesh_term>
	<criteria>Patients normal oral mucosa schedule receive radiation therapy head neck cancer enrol study . Patients previous head neck cancer and/or radiation therapy head neck area history/clinical evidence active significant acute chronic condition may compromise ability evaluate interpret effect study treatment mucositis exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Cancer</keyword>
	<keyword>Radiation therapy</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>Oral Mucositis</keyword>
	<keyword>SBG</keyword>
</DOC>